Neva can apply applicable Good Manufacturing Practices (GMP) as specified by the client. Neva has the analytical capability to support both characterization and specification-based testing across a range of medicinal products and materials including biologics, small molecules, gene therapy components and combination products from various R&D scenarios. 

As you focus on your core business activities of developing and evolving your intellectual property and its supporting data package, all of your outsourced partners need to have extensive experience knowing where they fit into your product’s research and development scheme. Then they need to deliver results which meet applicable data integrity and reliability expectations. 

Neva applies general Quality Management Principles to all key operations to support the delivery of reliable data. 

We can analyze active pharmaceutical ingredients (APIs), intermediates and investigational medicinal products (IMPs). 

Neva supports a range of R&D analytical needs including method development and qualification for biotech/pharmaceuticals active ingredients, intermediates, raw materials and finished products, as well as a variety of characterization testing on components and intermediates.

Starting with a middle ground perspective, we work with clients to understand their analytical needs and leverage our experience to tailor a solution that precisely meets quality, compliance and efficiency requirements in a ‘not too much, not too little’ approach. 

Test Methods & Turn Around Times

Client-specific custom methods,
Neva platform methods, USP
compendial methods and basic
wet chemistry analyses

After method set-up and/or verification is
complete, routine samples are typically
analyzed within 2-14 days of receipt –
based on the assay